cefaclor

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

65 documents for cefaclor

- Teva Announces Approval of Cefaclor ER Tablets.
Business Editors and Medical/Health Writers JERUSALEM, Israel--(BUSINESS WIRE)--Sept. 5, 2002 Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) a...
- Business Wire
- September 05, 2002
- A critical appraisal of the Department of Justice's new approach to medical marijuana.
... of one of Lilly's patent-expired drugs (cefaclor). The court found Lilly failed to satisfy the prox...
- Stanford Law & Policy Review
- Vol. 22 Nbr. 2, March 2011
- ESI Lederle Generics introduces cefaclor.
RADNOR, Pa.--(BUSINESS WIRE)--May 1, 1995--ESI Lederle Generics, a division of Wyeth-Ayerst Laboratories, announced today that its generic version of ...
- Business Wire
- May 01, 1995

- Eli Lilly and Company, Plaintiff-Appellant, v. American Cyanamid Company, Defendant-Appellee, and Biocraft Laboratories, Inc., Defendant-Appellee, and Zenith Laboratories, Inc., Defendant-Appellee, and Biochimica Opos, S.P.A., Defendant-Appellee., 82 F.3d 1568 (Fed. Cir. 1996)
... is a broad-spectrum antibiotic known as "cefaclor." Cefaclor is a member of the class of cephalospor...
- Federal Circuits
- Lilly ready to supply U.S. cefaclor market following recall of generic cefaclor manufactured by foreign sources.
INDIANAPOLIS--(BW HealthWire)--Feb. 26, 1997--Several U.S. distributors of cefaclor issued a voluntary recall of all oral forms of the antibiotic manu...
- Business Wire
- February 26, 1997
- Withdrawal of Approval of 70 New Drug Applications and 97 Abbreviated New Drug Applications:
...NDA 050521......... Ceclor (cefaclor). Eli Lilly and Co. Capsules, 250 mg and 500 mg. N...
- FR, June 08, 2011
- Notices
- Food and Drug Administration
- Drug eruptions: approaching the diagnosis of drug-induced skin diseases.
...Cefaclor is the most common cause of SSLR, but other drugs ...
- Journal of Drugs in Dermatology
- Vol. 2 Nbr. 3, June 2003
- IVAX Receives Approval for Cefaclor Extended-Release Tablets.
Business Editors MIAMI--(BUSINESS WIRE)--Jan. 8, 2001 IVAX Corporation (AMEX:IVX) received approval for the company's Abbreviated New Drug Applica...
- Business Wire
- January 08, 2001
- The potential for community exposures to pathogens from an urban dairy.
..., 10 [micro]g penicillin, and 30 [micro]g cefaclor) were selected because they were from two classes ...
- Journal of Environmental Health
- Vol. 74 Nbr. 7, March 2012
- Eli Lilly-Apotex patent litigation comes to an end.
... for the manufacture of the antibiotic "cefaclor." While four of the eight patents had been continu...
- Mondaq Business Briefing
- Nbr. 2010, January 2010